Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis

Reproduction

Volumn 123, Issue 2, 2002, Pages 217-226

  Gazvani, Rafet ^a   Templeton, Allan ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BASIC FIBROBLAST GROWTH FACTOR; COLONY STIMULATING FACTOR 1; CYTOKINE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; RANTES; SCATTER FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AGE; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; CELL GROWTH; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MENSTRUATION DISORDER; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERITONEAL FLUID; PERITONEUM; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; THEORY; UTERUS CAVITY;

ANIMALIA;

EID: 0036163342     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/rep.0.1230217     Document Type: Review

References (99)

1. Interleukin 6 in biology and medicine
2. Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture
3. Successful heterotransplantation of human endometrium in SCID mice
4. Regulation of monocyte chemotactic protein-1 gene expression in human endometrial cells in culture
5. Monocyte chemotactic protein-1 concentration in peritoneal fluid in patients with endometriosis and its modulation in human mesothelial cells
6. Interleukin 8 in the human endometrium
7. Interleukin 8 induces proliferation of endometrial stromal cells a potential autocrine growth factor
8. Current concepts: Immunology, Transplantation immunology
9. Cellular components in peritoneal fluid in infertile patients with and without endometriosis
10. Endometrial tissue in peritoneal fluid
11. Immunohistochemical analysis of oestrogen and progesterone receptors in endometriotic tissue and endometrium
12. Patterns of changes in proteins in the peritoneal fluid of women during the periovulatory phase of the menstrual cycle
13. Aromatase as a therapeutic target in endometriosis
14. Elevated interleukin 6 levels in peritoneal fluid of patients with pelvic pathology
15. Immunohistochemical analysis of insulin-like growth factor-I, insulin-like growth factor-1 receptor and insulin-like growth factor-II in endometriotic tissue and endometrium
16. Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGF beta-receptors in human endometrial tissue; localization and in vitro action
17. Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats
18. Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis
19. Induction of two distinct natural killer cell populations, activated T cells and antineoplastic cytokines, by interleukin 2 therapy in children with solid tumors
20. Endometriosis: Role of ovarian steroids in initiation, maintenance and suppression
21. Immunological aspects of endometriosis
22. The role of cell-mediated immunity in pathogenesis of endometriosis
23. Angiogenic factors
24. Intercellular adhesion molecule-1 and hepatocyte growth factor in human endometriosis: Original investigation and a review of literature
25. Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine
26. Vivo and in vitro effects of gamma-linolenic acid and eicosapentaenoic acid on prostaglandin production and arachidonic acid uptake by human endometrium
27. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro
28. Role of cytokines in progression of endometriosis
29. Immunology and endometriosis
30. Characterization of leukocyte subpopulations in the peritoneal fluid of women with endometriosis
31. + lymphocyte subpopulation are decreased in women with stage III-IV endometriosis
32. Peritoneal cellular immunity and endometriosis
33. + T lymphocytes in women with endometriosis
34. Epidermal growth factor and basic fibroblast growth factor in peritoneal fluid of women with endometriosis
35. Growth of the endometrial adenocarcinoma cell line AN3CA is up-regulated by estrogen in vitro
36. Sex steroids and growth factors differentially regulate the growth and differentiation of cultured human endometrial stromal cells
37. Pathogenetic significance of increased levels of interleukin 8 in the peritoneal fluid of patients with endometriosis
38. Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin 8 gene and protein expression
39. Endometriosis pathogenetic implications of the anatomic distribution
40. 2 alpha release by human peritoneal macrophages in endometriosis
41. Interferon-gamma and interleukin 6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis
42. The viability of the cast-off menstrual endometrium
43. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity fo endometriosis
44. Changes of peripheral blood lymphocyte subsets before and after operation of patients with endometriosis
45. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP-3 protease activity in the peritoneal fluid of patients with and without endometriosis
46. Interleukin 8 as a macrophage derived mediator of angiogenesis
47. Endometriotic disease: The role of peritoneal fluid
48. Soluble serum interleukin 2 receptor, interleukin 6 and interleukin 1a in patients with endometriosis and in controls
49. Paracrine changes in the peritoneal environment of women with endometriosis
50. Hepatocyte growth factor in renal disease: Cause or cure?
51. Interleukin 6 multifunctional cytokine regulating immune reactions and the acute phase protein response
52. Increased chemotactic activity of peritoneal fluid in patients with endometriosis
53. Changes in volume, total protein and ovarian steroid concentration of peritoneal fluid throughout the human menstrual cycle
54. Vascular endothelial growth factor and endometriotic angiogenesis
55. Decreased levels of a potent regulator of monocyte/macrophage activation, interleukin 13, in the peritoneal fluid of patients with endometriosis
56. Peritoneal fluid volume and sex steroids in the pre-ovulatory period in mild endometriosis
57. Vascular endothelial growth factor and interleukin 6 in peritoneal fluid of women with endometriosis
58. The actions of estradiol and epidermal growth factor in endometrial and endometriotic stroma in vitro
59. Peritoneal fluid interleukin 1-beta and tumor necrosis factor in patients with benign gynaecological disease
60. 2 stimulates aromatase expression in endometriosis-derived stromal cells
61. Pelvic endometriosis
62. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium
63. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis
64. Angiogenic activity of peritoneal fluid from women with endometriosis
65. Transforming growth factor β activity is increased in peritoneal fluid from women with endometriosis
66. The peritoneal environment in endometriosis
67. Hepatocyte growth factor concentrations are elevated in peritoneal fluid of women with endometriosis
68. A novel neutrophil-activating factor produced by human mononuclear phagocytes
69. Epidermal growth factor receptor expression in normal endometrium and endometriosis: An immunohistochemical study
70. Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenocarcinoma cells: Implications for the neovascularization of normal and neoplastic endometrium
71. Increased levels of interleukin 6 and interleukin 10 in the peritoneal fluid of patients with endometriosis
72. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis
73. Peritoneal fluid interleukin 6 in women with chronic pelvic pain
74. TNF-alpha secretion by peritoneal macrophages in endometriosis
75. Effects of transforming growth factor β on the functions of natural killer cells depressed cytolytic activity and blunting of interferon responsiveness
76. The development of the implantation theory for the origin of peritoneal endometriosis
77. Endometriosis in association with uterine anomaly
78. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
79. Basic fibroblast growth factor peritoneal and follicular fluid levels and its effect on early embryonic development
80. Immunology of endometriosis
81. Identification of epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in surgically induced endometriosis in rats
82. IL-1 stimulates IL-6 production in endothelial cells
83. Human endometrial stromal cells as a source of soluble intercellular adhesion molecule (ICAM)-1 molecules
84. Biology and action of colony-stimulating factor 1
85. Effect of platelet-derived growth factor on endometrial stromal cell proliferation in vitro a model for endometriosis
86. Antiproliferative effect of interferon-γ in human endometrial cells in vitro potential local growth modulatory role in endometrium
87. Experimental endometriosis
88. Altered gene expression and secretion of interleukin 6 in stromal cells derived from endometriotic tissues
89. Cytokines and the response to infection
90. Characteristics of human mononuclear phagocytes
91. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture
92. Peritoneal fluid and plasma levels of human macrophage colony-stimulating factor in relation to peritoneal macrophage content
93. The expression of soluble intercellular adhesion molecule 1 in endometriosis
94. Increase in the production of interleukin 6, interleukin 10, and interleukin 12 by lipopolysaccharide-stimulated peritoneal macrophages from women with endometriosis
95. Growth factor regulation of insulin-like growth factor binding protein secretion by cultured human granulosa-luteal cells
96. Prostaglandins in endometriosis
97. Secretion by human fibroblasts of monocyte chemoattractant protein-1, the product of gene JE
98. Human monocyte chemoattractant protein-1 (MCP-1) full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE
99. Effect of tumor necrosis factor α on adhesion of human endometrial cells to peritoneal mesothelial cells: An in vitro system